Target intelligence / Profile preview

Fc fragment of IgG binding protein (FCGBP)

Target
FCGBP
Molecular classification
Other (Secreted glycoprotein with multiple von Willebrand D domains; not a member of classical receptor/enzyme families)
01

Overview

Fc fragment of IgG binding protein (FCGBP) is a secreted, cysteine-rich glycoprotein predominantly found in mucus-secreting epithelia of the gastrointestinal, respiratory, and reproductive tracts[2][4][5]. It is composed of multiple von Willebrand D domains, enabling covalent linkage to mucins, which contributes to the structural organization and protection of the inner mucus layer[2][1]. FCGBP is co-secreted with peptides such as TFF1 and TFF3, implicating it in mucosal defense mechanisms[2]. Altered expression of FCGBP is observed in various cancers and inflammatory conditions, and its high expression is associated with advanced tumor grade and poor prognosis in glioma[1]. FCGBP is also implicated as a diagnostic and prognostic biomarker in multiple disease states, reflecting its dual function in both barrier integrity and immune response modulation[1][2][5]. The molecular function of FCGBP is still being elucidated, especially regarding its precise roles in immunity and tumor biology[1][2].

Other names
Fc gamma binding proteinIgG Fc binding proteinFCGBPFcgammaBPFC(GAMMA)BPfcgamma-binding protein antigenHuman Fc gamma BPFc fragment of IgG binding proteinIgGFc-binding proteinLOC100133944LOC435957
02

Mechanism of action

Not established for drugs; mechanisms suggested involve modulation of immune infiltration or tumor microenvironment as part of immunotherapy-related research, but no approved FCGBP-targeted agents

03

Biological functions

Mucosal innate immune defense: Organizes and helps protect mucus layers at epithelial surfacesImmune response modulation: Associated with immune cell infiltration in tumors, influencing tumor immunityBarrier integrity: Structural function by linking to mucins (e.g., covalent attachment to MUC2)Cancer biomarker: Expression levels correlate with tumor progression and prognosis in various cancers (glioma, ovarian, gallbladder, prostate)
04

Disease associations

Cancer (glioma, ovarian cancer, gallbladder adenocarcinoma, prostate cancer)Inflammation (as part of mucosal immune defense)Infection (linked to intra-amniotic infection in fluids)Liver disease (early diagnosis biomarker for alcoholic liver cirrhosis)
05

Safety considerations

None specific to FCGBP-targeted therapies, since no clinical agents currently target this proteinGeneral therapeutic challenges may include the complexity of modulating the mucosal immune environment or potential off-target effects if developed
06

Biomarkers

Prognostic biomarker for glioma (and other cancers)Biomarker for intra-amniotic infection (detected in amniotic/cervical fluid)Early diagnosis marker for liver cirrhosisExpression associated with immune infiltration markers (PD-L1, CCL2, CD8) in tumors

Beyond the preview

Go deeper on Fc fragment of IgG binding protein (FCGBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc fragment of IgG binding protein (FCGBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call